RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

raloxifene hydrochloride, Quantity: 60 mg

Beschikbaar vanaf:

MedTAS Pty Ltd

INN (Algemene Internationale Benaming):

Raloxifene hydrochloride

farmaceutische vorm:

Tablet, film coated

Samenstelling:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

Toedieningsweg:

Oral

Eenheden in pakket:

28 tablets

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

Product samenvatting:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2014-01-14